BioSpace News Archive

Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023.

Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Environmental, Social, and Governance (ESG) Report.

QurAlis Corporation and Unlearn today announced they have entered into a collaboration to accelerate and optimize QurAlis’ clinical program in ALS with Unlearn’s advanced generative artificial intelligence (AI) technology.

Lobe Sciences Ltd. today announced the initiation of a Phase 1, pharmacokinetic clinical study of L-130, a proprietary stabilized psilocin analogue drug candidate in healthy volunteers.

Emergent BioSolutions (NYSE: EBS, “Emergent” or the “Company”) today announced that Robert G. Kramer Sr. has informed the Board of Directors of his intention to retire from Emergent.

Predictive Oncology Inc. today announced the appointment of biopharmaceutical finance veteran Mr. Andrew Einhorn to its Business Advisory Board.

Kaléo, a fully integrated pharmaceutical company dedicated to creating innovative healthcare solutions to protect and empower patients, announced appointments at the C-suite and executive level to continue positioning Kaléo for growth in 2023 and beyond.

electroCore, Inc. (Nasdaq: ECOR) today announced that its TAC-STIM non-invasive vagus nerve stimulation (“nVNS”) Human Performance product, has been selected to be a part of the Air Force Research Laboratories (AFRL) Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments (A2PEX) Grant Program.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has recommended a positive opinion for orphan medicinal product designation for NUZYRA® (omadacycline) for the treatment of nontuberculous mycobacterial (NTM) lung disease.

Immutep Limited today announces the successful completion of an A$80 million capital raise to support its late-stage and expanding clinical development pipeline.